These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 19097588

  • 21. How will haematologists use proteomics?
    Unwin RD, Whetton AD.
    Blood Rev; 2007 Nov; 21(6):315-26. PubMed ID: 17889973
    [Abstract] [Full Text] [Related]

  • 22. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.
    Hu S, Yen Y, Ann D, Wong DT.
    Drug Discov Today; 2007 Nov; 12(21-22):911-6. PubMed ID: 17993408
    [Abstract] [Full Text] [Related]

  • 23. Cancer proteomics and its application to discovery of therapy response markers in human cancer.
    Smith L, Lind MJ, Welham KJ, Cawkwell L, Cancer Biology Proteomics Group.
    Cancer; 2006 Jul 15; 107(2):232-41. PubMed ID: 16752413
    [Abstract] [Full Text] [Related]

  • 24. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.
    Zou Y, Wang Y.
    J Proteome Res; 2007 Jun 15; 6(6):2304-14. PubMed ID: 17455969
    [Abstract] [Full Text] [Related]

  • 25. Proteomics of the heart: unraveling disease.
    McGregor E, Dunn MJ.
    Circ Res; 2006 Feb 17; 98(3):309-21. PubMed ID: 16484627
    [Abstract] [Full Text] [Related]

  • 26. Approaching Drosophila development through proteomic tools and databases: At the hub of the post-genomic era.
    Carmena A.
    Mech Dev; 2009 Oct 17; 126(10):761-70. PubMed ID: 19679183
    [Abstract] [Full Text] [Related]

  • 27. Direct tissue proteomics in human diseases: potential applications to melanoma research.
    Rezaul K, Wilson LL, Han DK.
    Expert Rev Proteomics; 2008 Jun 17; 5(3):405-12. PubMed ID: 18532908
    [Abstract] [Full Text] [Related]

  • 28. Proteomic analysis of human bile and potential applications for cancer diagnosis.
    Farina A, Dumonceau JM, Lescuyer P.
    Expert Rev Proteomics; 2009 Jun 17; 6(3):285-301. PubMed ID: 19489700
    [Abstract] [Full Text] [Related]

  • 29. Primary amine coding as a path to comparative proteomics.
    Regnier FE, Julka S.
    Proteomics; 2006 Jul 17; 6(14):3968-79. PubMed ID: 16800033
    [Abstract] [Full Text] [Related]

  • 30. Proteomics of bronchoalveolar lavage fluid.
    Wattiez R, Falmagne P.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb 05; 815(1-2):169-78. PubMed ID: 15652807
    [Abstract] [Full Text] [Related]

  • 31. Proteomic biomarker discovery for the monogenic disease cystic fibrosis.
    Penque D.
    Expert Rev Proteomics; 2007 Apr 05; 4(2):199-209. PubMed ID: 17425456
    [Abstract] [Full Text] [Related]

  • 32. Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.
    Srivastava G, Singh K, Tiwari MN, Singh MP.
    Expert Rev Proteomics; 2010 Feb 05; 7(1):127-39. PubMed ID: 20121482
    [Abstract] [Full Text] [Related]

  • 33. Urological malignancies and the proteomic-genomic interface.
    Unwin RD, Knowles MA, Selby PJ, Banks RE.
    Electrophoresis; 1999 Dec 05; 20(18):3629-37. PubMed ID: 10612290
    [Abstract] [Full Text] [Related]

  • 34. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M, Stojnev S, Stefanovic V.
    Ren Fail; 2010 Jan 05; 32(2):259-68. PubMed ID: 20199189
    [Abstract] [Full Text] [Related]

  • 35. Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective.
    Shukla HD, Vaitiekunas P, Cotter RJ.
    Proteomics; 2012 Oct 05; 12(19-20):3085-104. PubMed ID: 22890602
    [Abstract] [Full Text] [Related]

  • 36. Proteomics: new technologies and clinical applications.
    Latterich M, Abramovitz M, Leyland-Jones B.
    Eur J Cancer; 2008 Dec 05; 44(18):2737-41. PubMed ID: 18977654
    [Abstract] [Full Text] [Related]

  • 37. Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method.
    Castronovo V, Kischel P, Guillonneau F, de Leval L, Deféchereux T, De Pauw E, Neri D, Waltregny D.
    Proteomics; 2007 Apr 05; 7(8):1188-96. PubMed ID: 17372937
    [Abstract] [Full Text] [Related]

  • 38. Proteomics of pancreatic cancer.
    Gräntzdörffer I, Carl-McGrath S, Ebert MP, Röcken C.
    Pancreas; 2008 May 05; 36(4):329-36. PubMed ID: 18437077
    [Abstract] [Full Text] [Related]

  • 39. What does it need to be a biomarker? Relationships between resolution, differential quantification and statistical validation of protein surrogate biomarkers.
    Schrattenholz A, Groebe K.
    Electrophoresis; 2007 Jun 05; 28(12):1970-9. PubMed ID: 17516580
    [Abstract] [Full Text] [Related]

  • 40. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC, Chan CM, Ma BB, Lam MY, Choi GC, Au TC, Chan AS, Chan AT.
    Expert Rev Proteomics; 2009 Apr 05; 6(2):123-34. PubMed ID: 19385940
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.